Gavi proposal gives rich countries first crack at enough vaccine to cover 20% of their population, then poorer countries are guaranteed the vaccine.
Contribution includes $180 million to address humanitarian issues and $120 million for Access to COVID-19 Tools Accelerator.
Numerous rich countries have already ordered experimental shots and expect delivery even before vaccines are granted marketing approval.
Calls for fair access to ensure any new vaccine is distributed to poor countries.
Russia and Brazil now sit behind only the US in the number of reported cases, spiking from Mexico to India.
Will be building on work by a Chinese manufacturer that’s already conducting human clinical trials for the vaccine.
Accelerated effort is under way, helped by $8 billion pledged by leaders from 40 countries.
US a no-show, Britain’s envoy to Canada says the distribution of a new COVID-19 vaccine can’t be a competitive process.
60% of respondents believe people should be required to get the vaccine once it’s ready, 40% think it should be voluntary.
Industry’s rapid response is a reminder to support and protect biopharmaceutical innovation.
Task force created to oversee blood-test surveys to see how widely the virus has spread in Canada.
Even if the research goes well, a vaccine would not be available for widespread use for 12 to 18 months.
Agency says 55% of the total vaccine order is currently available to be distributed across the country.